Stocks

Alteogen Secures $150 Million to Expand Biopharmaceutical Operations

Guavy AI Editorial Team Published October 7, 2026

Instruments

MRK

Alteogen Inc. has secured 200 billion won ($150 million) in funding from the National Growth Fund and SkyLake Equity Partners. The investment will support the construction of a new biopharmaceutical manufacturing facility in Daejeon and the acquisition of new drug pipelines and technologies…

The Wire

Read the full article for free.

A free account opens the rest of this article, how it scored, and the full Wire stream. No card required.

Create free account Already have an account? Sign in

No spam. Unsubscribe anytime.

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

GUAVY

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

Navigate

Markets

Resources

Terms Privacy Policy